HomePfizer’s $11.6 billion Biohaven buy could spark more biotech dealsFILE PHOTO: A person walks past the Pfizer Headquarters building

FILE PHOTO: A person walks past the Pfizer Headquarters building

FILE PHOTO: A person walks past the Pfizer Headquarters building in the Manhattan borough of New York City, New York, U.S., December 7, 2020. REUTERS/Carlo Allegri/File Photo
FILE PHOTO: Biohaven Pharmaceutical Holding Company logo is displayed on
- Advertisment -
Google search engine

Most Read